Renal albumin absorption in physiology and pathology

Slides:



Advertisements
Similar presentations
ATHEROSCLEROSIS THE HDL RECEPTORS A REVIEW AND
Advertisements

Hepatocyte growth factor in renal failure: Promise and reality
Pharmacokinetics of Peptide and Protein Therapeutics
In normal individuals, amino acids gain access to the proximal nephron cells (left-hand arrows) through the apical microvilli or through the infoldings.
Two-photon microscopy: Visualization of kidney dynamics
Volume 75, Issue 12, Pages (June 2009)
The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor- mediated endocytic route in response to parathyroid hormone  D. Bacic,
Hepatocyte growth factor in renal failure: Promise and reality
Volume 80, Issue 12, Pages (December 2011)
Volume 65, Issue 6, Pages (June 2004)
Volume 73, Issue 4, Pages (February 2008)
Volume 66, Pages S5-S12 (October 2004)
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 72, Issue 4, Pages (August 2007)
Volume 55, Issue 4, Pages (April 1999)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 69, Issue 10, Pages (May 2006)
Volume 96, Issue 4, Pages (February 1999)
Volume 70, Issue 1, Pages (July 2006)
Proximal tubular handling of phosphate: A molecular perspective
Proximal Tubular Function.
Volume 71, Issue 6, Pages (March 2007)
Actin cytoskeleton in ischemic acute renal failure
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Volume 59, Issue 2, Pages (February 2001)
Volume 62, Issue 3, Pages (September 2002)
A trail of research on potassium
Volume 60, Issue 4, Pages (October 2001)
Volume 61, Issue 4, Pages (April 2002)
Volume 58, Issue 4, Pages (October 2000)
Transcriptional regulation of the NPT2 gene by dietary phosphate
Autosomal dominant distal renal tubular acidosis and the AE1 gene
Volume 62, Issue 1, Pages (July 2002)
Volume 53, Issue 5, Pages (May 1998)
Bioavailable vitamin D in chronic kidney disease
Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell Neoplasms  Yongsheng Ma, B. Jack Longley, Xiaomei Wang 
Molecular pathogenesis of ADPKD: The polycystin complex gets complex
A ‘complexity’ of urate transporters
Oliver Vonend, Clare M. Turner  Kidney International 
Jasper S. Weinberg, David G. Drubin  Current Biology 
Volume 54, Issue 2, Pages (August 1998)
Volume 67, Issue 2, Pages (February 2005)
FAT is a component of glomerular slit diaphragms
Transfer of Cholesterol by the NPC Team
Antigen Presentation: Kissing cousins exchange CLIP
The molecular biology of thrombotic microangiopathy
Volume 53, Issue 5, Pages (May 1998)
Carol M. Herak-Kramberger, Dennis Brown, Ivan Sabolić 
Volume 78, Issue 5, Pages (September 2010)
Rik van der Kant, Lawrence S.B. Goldstein  Developmental Cell 
The L1 cell adhesion molecule is a potential biomarker of human distal nephron injury in acute tubular necrosis  Y. Allory, V. Audard, P. Fontanges, P.
Ayman El-Sayed, Hideyoshi Harashima  Molecular Therapy 
Pathophysiology of proteinuria
Volume 84, Issue 5, Pages (November 2013)
Volume 72, Issue 10, Pages (November 2007)
Volume 71, Issue 4, Pages (February 2007)
Volume 5, Issue 3, Pages (March 1997)
Renal potassium channels: Function, regulation, and structure
Chapter 13 Intracellular Vesicular Traffic.
T. Maritzen, G. Rickheit, A. Schmitt, T.J. Jentsch 
The molecular biology of thrombotic microangiopathy
Two-photon microscopy: Visualization of kidney dynamics
Latest findings in phosphate homeostasis
Volume 71, Issue 3, Pages (February 2007)
Genetics of hypercalciuric stone forming diseases
Leileata M. Russo, Wayne D. Comper, Tanya M. Osicka 
Volume 70, Issue 6, Pages (September 2006)
Volume 72, Issue 4, Pages (August 2007)
Glomerular binding of anti-dsDNA autoantibodies: The dispute resolved?
Exosomes and Ectosomes in Intercellular Communication
Presentation transcript:

Renal albumin absorption in physiology and pathology H. Birn, E.I. Christensen  Kidney International  Volume 69, Issue 3, Pages 440-449 (February 2006) DOI: 10.1038/sj.ki.5000141 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Schematic representation showing the structure of megalin, cubilin, and AMN. Megalin is a 4600-amino-acid transmembrane protein with a non-glycosylated molecular weight of 517 kDa. The extracellular domain (∼4400 amino acids) contains four cysteine-rich clusters of low-density lipoprotein receptor type A repeats constituting the ligand binding regions separated and followed by a total of 17 EGF-type repeats and eight spacer regions containing YWTD repeats. A single transmembrane domain (22 amino acids) is followed by the cytoplasmic tail (213 amino acids), which contains two NPXY sequences and one VENQNY sequence in addition to several Src homology 3 and one Src homology 2 recognition sites. Cubilin is a 3600-amino-acid protein with no transmembrane domain and a non-glycosylated molecular weight of ∼400 kDa. The extracellular domain contains 27 CUB domains constituting molecular basis for interaction with multiple other proteins. The CUB domains are preceded by a stretch of 110 amino acids followed by eight EGF-type repeats. The amino-terminal region contains a potential palmitoylation site and an amphipathic helix structure with some similarity to the lipid binding regions of apolipoproteins. AMN is a 434-amino-acid, single-transmembrane protein with a non-glycosylated molecular weight of ∼46 kDa. It has no known, closely related proteins, but a cysteine-rich stretch of 70 amino acids in the extracellular domain has similarity to modules present in a small group of proteins serving as bone morphogenic protein inhibitors. Both AMN and megalin bind cubilin and studies indicate that both are involved in the endocytosis of this receptor. Kidney International 2006 69, 440-449DOI: (10.1038/sj.ki.5000141) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Immunocytochemical localization of cubilin and uptake of endogenous albumin in cryosections of dog kidney cortex. In normal dog kidney, (a) intense labeling for cubilin (green fluorescence) is observed at the luminal brush border and in endocytic vesicles co-localizing with reabsorbed albumin (red fluorescence) reflecting endocytosis of filtered protein. Apical vesicles reveal co-localization of cubilin and albumin as indicated by the yellow label (arrows in a). In dogs with a mutation in the AMN, gene-causing defective insertion of cubilin into the apical membranes, (b) cubilin is retained in intracellular vesicles and no evidence of endocytic uptake of albumin is observed. Only a sparse labeling for albumin can be identified in the tubular lumen and along the apical membrane, the latter possibly reflecting binding to megalin (arrows in b). One micrometer cryosections from perfusion fixed dog kidneys were incubated with rabbit anti-dog cubilin (1:200) and sheep anti-rat albumin (1:200) primary antibodies followed by incubation with Alexa Flour 488 donkey anti-rabbit and Alexa Fluor 546 donkey anti-sheep fluorescence labelled secondary antibodies. Bars=10 μm. Kidney International 2006 69, 440-449DOI: (10.1038/sj.ki.5000141) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Pathways of albumin handling in the kidney. Albumin is filtered in the glomeruli (1) and reabsorbed by the proximal tubule cells by receptor-mediated endocytosis (2a). Internalization by endocytosis is followed by transport into lysosomes for degradation. Classically, this is considered to result in the formation of free amino acids released into the circulation (2b); however, it has been recently suggested that significant amounts of albumin fragments are excreted in the urine, possibly resulting from tubular degradation of filtered albumin (2c). Some intact albumin may escape tubular reabsorption (3), the amount being greater as the glomerular filtration fraction of albumin increases or tubular function is compromised. The upper right shows a schematic representation of the intracellular pathways following endocytic uptake of albumin and possible associated substances. Following binding to the receptors, cubilin or megalin, the receptor–albumin complex is directed into coated pits for endocytosis, a process that may also involve AMN. The complex dissociates following vesicular acidification most likely also leading to the release of any bound substances. Albumin is transferred to the lysosomal compartment for degradation. Some albumin may be degraded within a late endocytic compartment and recycled as fragments to be released at the luminal surface. Alternatively, albumin fragments may be recycled from the lysosomal compartment by a yet unknown route. Receptors recycle through dense apical tubules, whereas released substances carried by albumin may be released into the cytosol or transported across the tubular cell. An alternative high-capacity retrieval pathway for non-degraded albumin located immediately distal to glomerular basement membrane has been proposed (4); but yet not characterized. Misdirected filtration of albumin into the interstitium resulting from pathological, glomerular changes has been proposed as a pathway for progression of renal disease (5). Kidney International 2006 69, 440-449DOI: (10.1038/sj.ki.5000141) Copyright © 2006 International Society of Nephrology Terms and Conditions